Investors file involuntary bankruptcy petition against Jiangbo Pharmaceuticals

Jiangbo, a Florida corporation headquartered in China, was facing SEC administrative proceedings for failing to file its 2011 annual report and three quarterly reports.

This article requires premium access

This article requires premium access to Daily Business Review. Please sign in or subscribe to read the full text.